Update on tubulin-binding agents
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference127 articles.
1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;New Engl. J. Med.,2004
2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;New Engl. J. Med.,2004
3. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer;Chan;J. Clin. Oncol.,1999
4. Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial;Nabholtz;J. Clin. Oncol.,2003
5. Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group;Nabholtz;J. Clin. Oncol.,1999
Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sequential Endoluminal Gemcitabine and Cabazitaxel with Intravenous Pembrolizumab as a Bladder-Preserving Strategy for Docetaxel-Unresponsive Non-Muscle Invasive Urothelial Carcinoma Following Transurethral Resection of Bladder Tumor;Cancers;2024-07-17
2. Combretum Caffrum Confers a Potential CuttingEdge Anticancer Molecule as Combretastatins;The Chemistry inside Spices & Herbs: Research and Development;2024-07-04
3. Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel;Discover Oncology;2024-05-10
4. Anticancer activity of natural compounds from stems/barks of the plants;Natural Products as Anticancer Agents;2024
5. The Blocking of Drug Resistance Channels by Selected Hydrophobic Statins in Chemoresistance Human Melanoma;Biomolecules;2023-11-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3